Ralph J Hauke
8PUBLICATIONS
100CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Feb 22, 2026
Phase 1 Study of INBRX-105, a TNFRSF9 (4-1BB) and PD-L1 Bispecific Antibody, in Patients with Select Solid Tumors.Jong Chul Park, David Berz, Manish R Sharma
|Jan 27, 2026
Phase 1 Study of INBRX-105, a TNFRSF9 (4-1BB) and PD-L1 Bispecific Antibody, in Patients With Select Solid Tumors.Jong Chul Park, David Berz, Manish R Sharma
|Feb 18, 2025
COSMIC-021 Phase Ib Study of Cabozantinib Plus Atezolizumab: Results from the Locally Advanced or Metastatic Urothelial Carcinoma Cohorts.Sumanta K Pal, Yohann Loriot, Andrea Necchi
|Aug 22, 2024
Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy.Elisabeth Heath, Gregory Dyson, Jennifer R Ribeiro
|Aug 03, 2023
A Phase II Trial of the CD40 Agonistic Antibody Sotigalimab (APX005M) in Combination with Nivolumab in Subjects with Metastatic Melanoma with Confirmed Disease Progression on Anti-PD-1 Therapy.Sarah A Weiss, Mario Sznol, Montaser Shaheen
|Mar 31, 2023
SALVO: Single-Arm Trial of Ipilimumab and Nivolumab as Adjuvant Therapy for Resected Mucosal Melanoma.Lisa A Kottschade, Gregory Russell Pond, Anthony J Olszanski
Pageof 2
Frequent Collaborators
2 joint publications
Jyoti Malhotra
2 joint publications
Erminia Massarelli
2 joint publications
John T Hamm
2 joint publications
Anthony W Tolcher
2 joint publications
Naomi B Haas
2 joint publications
Manish R Sharma
2 joint publications
Mohammed Milhem
2 joint publications
Rachel E Sanborn
2 joint publications
Justin A Call
2 joint publications
David Berz
